Atlas Trials

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

Clinical trial NCT01093534 · COMPLETED

Trial details

NCT number
NCT01093534
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Detrusor OveractivityOveractive Bladder
Start date
2010-01-19
Primary completion
2011-06-23
Enrollment
547

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.